Breaking: India Biologics Market Seen Surging Towards $166.91 Billion by 2035
The India Biologics Market is set for remarkable expansion, projected to reach an impressive $166.91 billion by 2035. This growth trajectory reflects a compound annual growth rate (CAGR) of 16.888% from its current valuation. The demand for biologics, particularly monoclonal antibodies and vaccines, is being driven by a need for affordable healthcare solutions in a country with a burgeoning...
0 Condivisioni
25 Visualizzazioni